Clostridium Difficile Infection
- 2024 CPG – Guideline for the Management of Clostridioides difficile Infection in Pediatric Patients with Cancer and Hematopoietic Cell Transplantation Recipients: 2024 Update (open access at eClinicalMedicine)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2018 CPG – Guideline for the management of clostridium difficile infection in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation recipients (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Antibacterial Prophylaxis
Antifungal Prophylaxis
Chemotherapy-Induced Nausea and Vomiting
Acute delayed Phase CINV
Anticipatory CINV
Breakthrough and Refractory CINV
Emetogenicity Classification
Acute and Delayed Phase CINV
Chronic Pain*
Clostridium Difficile Infection
Fatigue
Fertility Preservation*
Mucositis
Ototoxicity
Fever and Neutropenia
Food Restrictions
Platelet Transfusion*
Venous Thromboembolism*
Care Pathways
YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.